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The ultimate goal of any dental treatment is the regeneration of lost tissues and alveolar bone. Under the appropriate culture
conditions, periosteal cells secrete extracellular matrix and form a membranous structure. The periosteum can be easily harvested
from the patient’s own oral cavity, where the resulting donor site wound is invisible. Owing to the above reasons, the periosteum
oﬀers a rich cell source for bone tissue engineering; hence, the regenerative potential of periosteum is immense. Although the
use of periosteum as a regenerative tool has been extensive in general medical ﬁeld, the regenerative potential of periosteum is
highly underestimated in dentistry; therefore, the present paper reviews the current literature related to the regenerative potential
of periosteum and gives an insight to the future use of periosteum in dentistry.
1.Introduction
Reconstruction of lost tissues is a long cherished goal in
medical ﬁeld. A lot of research has been done in the
past, and still research is going on to explore tools and
techniques for regeneration of lost tissues as a result of
the disease process. The use of various grafts and recent
tissue engineering techniques including stem cell research
are testimony to the ever increasing need for most suitable
treatment option to replace/repair lost tissues due to various
pathologic processes. The use of autogenous periosteum in
general medical treatment has been extensive and has shown
promising results [1–3]; on the contrary in dentistry, the
use of periosteum as a regenerative tool has been limited
and highly underrated; therefore, the purpose of this paper
is to highlight the current status of use of periosteum in
dentistry as well as suggesting its future use in various
treatment options related speciﬁcally to dental ﬁeld.
2. Periosteum: What Justiﬁes Its Use?
The periosteum is a highly vascular connective tissue sheath
covering the external surface of all the bones except for sites
of articulation and muscle attachment (Figure 1)[ 4]. The
periosteum comprises of at least two layers, an inner cellular
or cambium layer, and an outer ﬁbrous layer [1]. The inner
layer contains numerous osteoblasts and osteoprogenitor
cells, and the outer layer is composed of dense collagen
ﬁber, ﬁbroblasts, and their progenitor cells [5]; osteogenic
progenitor cells from the periosteal cambium layer may
work with osteoblasts in initiating and driving the cell
diﬀerentiation process of bone repair characterized by the
development of the initial fracture callus and subsequent
remodeling. Periosteum can be described as an osteoprogen-
itor cell containing bone envelope, capable of being activated
to proliferate by trauma, tumors, and lymphocyte mitogens
[6]. Research on the structure of periosteum has shown
that it is made up of three discrete zones [7]. Zone 1 has
an average thickness of 10–20um consisting predominantly
of osteoblasts representing 90% of cell population, while
collagen ﬁbrils comprise 15% of the volume. The majority
of cells in zone 2 are ﬁbroblasts, with endothelial cells being
most of the remainder. Zone 3 has the highest volume of
collagen ﬁbrils and ﬁbroblasts among all the three zones.
Fibroblasts take up more than 90% of the cells in zone 3. The
morphology of ﬁbroblasts is variable across the three zones
(Figure 2).
The structure of periosteum varies with age. In infants
and children it is thicker, more vascular, active, and loosely
attachedascomparedto adultswhereit is thinner, less active,
and ﬁrmly adherent [8]. In all age groups, the cells of the
periosteum retain the ability to diﬀerentiate into ﬁbroblasts,2 International Journal of Dentistry
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Figure 1: Highly vascular periosteum covering the alveolar bone.
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Figure 2: The three diﬀerent Zones of periosteum; Zone 1 has an average thickness of 10–20um consisting predominantly of osteoblasts;
the majority of cells in Zone 2 are ﬁbroblasts, with endothelial cells being most of the remainder. Zone 3 has the highest volume of collagen
ﬁbrils among all the three zones. The bottom of the ﬁgure shows regenerative capacity of the periosteum to form diﬀerent cell types.
osteoblasts, chondrocytes, adipocytes, and skeletal myocytes.
The tissues produced by these cells include cementum with
periodontal ligament ﬁbers and bone. The periosteum has a
rich vascular plexus and is regarded as the “umbilical cord
of bone” [9]. The vasculature system of the periosteum was
ﬁrst studied in detail by Zucman and later by Eyre-Brook
[10]. Bourke’s studies showed that the capillaries supplying
blood to bone reside within the cortex linking the medullary
and periosteal vessels; a recent study has even shown that
periosteal cells release vascular endothelial growth factor
[11]whichpromoterevascularizationduringwoundhealing.
Recently, studies have reported the existence of osteogenic
progenitors, similar to mesenchymal stem cells (MSCs),
in the periosteum [12, 13]. Under the appropriate culture
conditions, periosteal cells secrete extracellular matrix and
form a membranous structure [14]. The periosteum can beInternational Journal of Dentistry 3
easily harvested from the patient’s own oral cavity, where
the resulting donor site wound is invisible. Owing to the
above reasons, the periosteum oﬀers a rich cell source for
bone tissue engineering; hence, the regenerative potential of
periosteum is immense.
3.PeriosteumasaTool inMedicine
andDentistry
Developing bone substitutes for bone defect repair has
inspired orthopedic surgeons, bone biologists, bioengineer-
ing researchers to work together in order to design and
develop the promising products for clinical applications.
Duhame in the year 1742 can be considered the ﬁrst
investigator to study the osteogenic potential of periosteum
and published his ﬁndings in the article “Sur le Development
etlaCruededOsdesAnimaux”[15].Acenturylater,another
French surgeon, Ollier, discovered that the transplanted
periosteum could induce de novo bone formation. One of
the earliest experimental studies to demonstrate osteogenic
potential of periosteum was that of Urist and McLean who
reported that periosteum produced bone when transplanted
to the anterior chamber of the eye of the rat [16]. Skoog
subsequently introduced the use of periosteal ﬂaps for
closure of maxillary cleft defects in humans; he reported the
presence of new bone in cleft defects within 3–6 months
following surgery [17]. Since then, surgeons have reported
thesuccessfuluseofmaxillaryperiostealﬂaps[18,19]asw ell
as periosteal grafts from the tibia or rib. Melcher observed
thatnewboneislaiddowninparietalbonedefectsofratsand
was deposited by periosteum that had not been previously
elevated or disturbed in any other way [20], while other
investigators have suggested that the contact between the
periosteal ﬂap or graft and the underlying bone is crucial
to stimulation of osteogenesis [21, 22]. More recently, the
osteogenic/chondrogenic capacity of periosteum and related
mechanisms have been conﬁrmed, and the underlying
biology is better understood through a number of studies
[23–40].
The use of periosteum in dentistry is not new. Var-
ious research papers have been published explaining the
osteogenic potential of human periosteal grafts [41, 42]. The
useofperiosteumasaGTRhasbeensuggestedbyman ystud-
ies [43–46], although long-term results are still awaited to
establish the regular and the most eﬀective use of periosteal
grafts as barrier membranes. The need for a graft, which has
its own blood supply, which can be harvested adjacent to
the recession defect in suﬃcient amounts without requiring
any second surgical site and has a potential of promoting the
regenerationoflostperiodontaltissueisalong-feltneed.The
adult human periosteum is highly vascular and is known to
contain ﬁbroblasts and their progenitor cells, osteoblasts and
their progenitor cells, and stem cells. In all the age groups,
the cells of the periosteum retain the ability to diﬀerentiate
into ﬁbroblasts, osteoblasts, chondrocytes, adipocytes, and
skeletal myocytes. The tissues produced by these cells include
cementum with periodontal ligament ﬁbers and bone; in
addition the presence of periosteum adjacent to the gingival
recession defects in suﬃcient amounts make it a suitable
graft. Recent papers published have shown promising results
with the use of periosteum in the treatment of gingival
recession defects (Figure 3)[ 47, 48]; moreover, with the
advancement in tissue engineering techniques the periosteal
derived stem cells have been grown eﬀectively to reconstruct
lost tissues. Periosteum-derived progenitor cells may serve
as an optimal cell source for tissue engineering based on
their accessibility, ability to proliferate rapidly, and capability
to diﬀerentiate into multiple mesenchymal lineages. The
periosteum is a specialized connective tissue that forms a
ﬁbrovascularmembranecoveringallbonesurfacesexceptfor
that of articular cartilage, muscle, and tendon insertions and
sesamoid bones. Cells residing within the periosteum may
be excised from any number of surgically accessible bone
surfaces; in addition, when properly stimulated, the perios-
teum has the potential to serve as a bioreactor supporting a
dramatic increase in the progenitor cell population over the
courseofafewdays.Further,oncethecellsareremovedfrom
theperiosteum,theyhavethepotentialtoproliferateatmuch
higher rates than bone marrow, cortical bone, or trabecular
bone-derived progenitor cells [49].
Inadditiontotheirrobustproliferationaptitude,itiswell
established that periosteum-derived progenitor cells have
the potential to diﬀerentiate into both bone and cartilage.
Further, their potential for regenerating both bone and
cartilage constructs is superior to that of adipose-derived
progenitor cells and comparable with that of bone marrow-
derived mesenchymal stem cells. A recent study by De Bari
et al. indicates that periosteal progenitor cells are able to
diﬀerentiate not only into bone and cartilage cells but also
into adipocyte and skeletal myocyte cells [50]. There is a
growing requirement for dentists to regenerate alveolar bone
as a regenerative therapy for periodontitis and in implant
dentistry. Concerning the donor site, it is easier for general
dentists to harvest periosteum than marrow stromal cells,
because they can access the mandibular periosteum during
routine oral surgery [51]; also the regenerative potential of
periosteum has been eﬀectively used in “osteodistraction”
which has the beneﬁt of simultaneously increasing the bone
length and the volume of surrounding tissues. Although
distraction technology has been used mainly in the ﬁeld
of orthopedics, early results in humans indicated that the
process can be applied to correct deformities of the jaw.
These techniques are now utilized extensively by maxillofa-
cial surgeons for the correction of micrognathia, midface,
and fronto-orbital hypoplasia in patients with craniofacial
deformities [52].
4. Conclusion
The use of periosteum can revolutionize the success of vari-
ousdentaltreatmentswhichrequireeitherboneorsofttissue
regeneration; particularly the future use of periosteum must
be explored in periodontal and implant surgical procedures.
Although the regenerative potential of periosteum has been
proved by numerous studies, till date the use of periosteum-
derived grafts has still not become a standard tool in the4 International Journal of Dentistry
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Figure 3: The use of periosteum for the treatment of gingival recession defect. (a) Clinical photograph showing gingival recession defect
in relation to the maxillary ﬁrst right premolar. (b) A partial thickness ﬂap lifted to expose the underlying periosteum covering the alveolar
bone. (c) The periosteum which is separated from the underlying bone. (d) The periosteum is used as a pedicle graft for covering the
recession defect. (e) The periosteal graft is covered with the overlying coronally advanced ﬂap which is sutured using 4–0 silk suture. (f)
Satisfactory treatment outcome.
armamentarium of dental surgeons, and it may still need
some time, and further research before the full regenerative
potential of periosteum is utilized.
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